Definium Therapeutics, Inc. (“Definium” or the “Company”), announced results from a retrospective, longitudinal study published in the Journal of Mood and Anxiety Disorders examining the real-world ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results